Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-03-07 00:00:00 ET · period of report 2025-03-05 · accession 0001765581-25-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-07 | 2025-03-05 | JAZZ | Johnson Philip L | EVP, CFO | D - Sale to Iss | $138.95 | -1,149 | 50.1K | -2% | -$159.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-05 | D | D | 1,149 | $138.95 | 50,060 | D | — | — |